Clinical trials recruiting for Advanced HR+/HER2- Breast Cancer
Fewer than 3 recruiting trials found.
2
Recruiting trials
4
US states with sites
12
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 2Phase 2 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Fulvestrant | 2 |
| Letrozole | 2 |
| GVV858 | 1 |
| IEV407 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Texas | 2 |
| Connecticut | 1 |
| Georgia | 1 |
| Tennessee | 1 |
Top cities
Self-screener
Recruiting trials
- Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
- Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer
Related conditions
Trials recruiting for Advanced HR+/HER2- Breast Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Advanced HR+/HER2- Breast Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.